Without naming a specific product, Commissioner Marty Makary referred to an investigational therapy, delivered surgically into the brain, that the FDA was “pressured” to approve even after finding no ...

For starters, it’s not simply absent one day and fully present the next.

As Sarah Ferguson checks out of the world's most expensive rehab, we revisit what makes Paracelsus a perfect retreat for the disgraced.

Diana Shaw of Wiley Rein LLP examines a recent HHS Office of Inspector General advisory on direct-to-consumer prescription ...

Users usually easily exit from AI chatbots. But what about when in a dire mental state? The AI might snag you. Should there ...

Wednesday night marked a special moment for Cruz as it marked his first performance with his band, Cruz Beckham and The ...

Jazz Pharmaceuticals plc ( JAZZ) Q4 2025 Earnings Call February 24, 2026 4:30 PM EST Good day, and thank you for standing by. Welcome to the Jazz Pharmaceuticals Fourth Quarter 2025 Earnings ...

Remarks the FDA commissioner made during a CNBC appearance seemed to stoke investor fears that UniQure's gene therapy for Huntington's won't get approved.

Spring Health reports that organizations should identify and prevent regrettable attrition by recognizing early warning signs, such as employee burnout, before it leads to turnover.

“We have discovered that people carrying rare, naturally occurring mutations in a gene called CHRNB3 tend to smoke significantly fewer cigarettes per day,” explain the study’s lead authors, ...

Ongoing Phase 3 full approval clinical trial of ateganosine holds high probability of technical success for interim and full analysisFDA Fast ...

Good afternoon. Thank you for attending today's Teladoc Health Q4 2025 Earnings Conference Call. My name is Tamia, and I will be your moderator for today's call. [Operator Instructions] I would now ...